| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 13. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | macimorelin aeterna zentaris (Macimorelin®) |
| Formulation | 60 mg granules for oral suspension |
| Reference number | 3551 |
| Indication | Diagnosis of growth hormone deficiency in adults |
| Company | Æterna Zentaris Inc |
| BNF chapter | Endocrine system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 14/01/2019 |